Hepion Pharmaceuticals Inc. (HEPA) Fundamentals

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. Its cyclophilin inhibitor, CRV431, is being developed to offer benefits to address these multiple complex pathologies. CRV431 is a pan cyclophilin inhibitor that targets multiple pathologic pathways involved in the progression of liver disease.
SHARE INFORMATION
Market Cap$ 53,343,258
Shares Outstanding76,226,433
Float76,114,828
Percent Float99.85%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.47
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions75
Institutional Holdings Date2022-04-30
Institutional Bought Previous 3 Months202,650
Institutional Holdings Percent21.5%
Institutional Sold Previous 3 Months283,167
Insider Holdings Date2022-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent1.0
Insider Sold Previous 3 Months-
Insider Shares Owned738,772
TRADING INFO
52 Week High$ 2.32
52 Week Low$ 0.61
52 Week High Change$ -58.84
21 Day Moving Average$ 0.8718
21 Day Extended Moving Average$ 0.851333
50 Day Moving Average$ 1.0316
50 Day Extended Moving Average$ 0.969024
200 Day Moving Average$ 1.2573
200 Day Extended Moving Average$ 1.2754
10 Day Average Volume360,816
20 Day Average Volume284,481
30 Day Average Volume249,311
50 Day Average Volume266,710
Alpha-0.081570
Beta1.4015
Standard Deviation0.266533
R20.061958
7 Day Price Change$ -0.0891
7 Day Percent Change-11.29%
21 Day Price Change$ -0.2387
21 Day Percent Change-25.43%
30 Day Price Change$ -0.3502
30 Day Percent Change-33.35%
Month to Date Price Change$ -0.2274
Month to Date Percent Change-24.53%
Quarter to Date Price Change$ -0.5902
Quarter to Date Percent Change-45.75%
180 Day Price Change$ -0.6802
180 Day Percent Change-49.29%
200 Day Price Change$ -0.7302
200 Day Percent Change-51.06%
Year to Date Price Change$ -0.4402
Year to Date Percent Change-38.61%

Hepion Pharmaceuticals Inc. (HEPA) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.70
Total Debt To Equity0.00
Int Coverage-3,692.70
Current Ratio11.90
Leverage Ratio1.10
Quick Ratio11.10
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-1.60
Enterprise Value$ -33,677,929
Price to Sales0.00
Price to Free Cash-2.30
PE High Last 5 Years-0.30
Price To Book0.60
Price To Cash Flow0.00
PE Low Last 5 Years-0.60
Price to Tangible Book0.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-43.97
Return on Equity-51.36
Return on Capital-49.88

Hepion Pharmaceuticals Inc. (HEPA) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorBDO USA, LLP
CEORobert T. Foster
Emplyoees20
Last AuditUQ
CIK0001583771
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address399 Thornall Street
1st Floor
Edison, NJ 8837
Websitehttps://www.hepionpharma.com
Facsimile+1 732 902-4100
Telephone+1 732 902-4000
Emailinfo@hepionpharma.com


Your Recent History
NASDAQ
HEPA
Hepion Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.